From WORLD Feb 8, 2013

DNA testers latch on to scandal

Full tests cost £300 and can check for only one species

Feb 8, 2013

Sanofi forecasts possible earnings dip

Fourth-quarter core profits down 24%

From HEALTH CARE Feb 7, 2013

S&N solid finish outweighs weaker outlook

Good news on knee implants and wound management buoy Smith & Nephew

Feb 6, 2013

Biogen to buy Elan’s stake in MS drug

US biotechnology company to pay $3.25bn in cash for full control of Tysabri

The logo of GlaxoSmithKline Plc hangs outside the company's headquarters ©Getty Feb 6, 2013

GSK unveils European restructuring plans

Lucozade and Ribena drinks brands placed under review

From LEX Feb 6, 2013

Elan / Biogen: where are the drugs?

Biotech group needs a new strategy now more than ever

Feb 5, 2013

Campaigners welcome GSK disclosure move

Clinical study reports to be released

Metal-free microneedles could help tackle trypanophobia - the fear of needles - as well as make vaccination easier in tropical countries ©Getty From TECHNOLOGY Feb 4, 2013

Needle-free syringe passes test on mice

Technique could improve distribution of fragile vaccines

Hasegawa, Takeda From MANAGEMENT Feb 4, 2013

A new corporate focus

When Japanese pharma company Takeda tried to become more global, changing its internal culture started at the top

John Authers from FINANCIALS Feb 3, 2013

Activist spat distracts from real targets

All the signs suggest this is a great time to take aim at boards

Jan 31, 2013

AstraZeneca warns of tough year ahead

Focus at Anglo-Swedish drugmaker is on organic growth

Jan 31, 2013

Zoetis raises $2.24bn in IPO

Pfizer spin-off is largest listing since Facebook

From LEX Jan 31, 2013

AstraZeneca: don’t look now

Anglo-Swedish drugmaker’s results reflect how tough restoration will be

Jan 30, 2013

Roche boosted by robust US sales

Swiss pharma group expects European market to remain weak

Jan 29, 2013

Pfizer hints core drugs unit may be split

Group in market for ‘bolt-on’ acquisitions

Jan 28, 2013

Sanofi launches talking injection device

Device for people suffering from extreme allergic reactions

Jan 28, 2013

SThree focuses on contracts as profits fall

Recruiter joins in ‘land grabbing’ in markets outside of the UK

Jan 28, 2013

Move to disclose payments to doctors

Concern on potential conflicts of interest sparks public consultation

Case Study from MANAGEMENT Jan 28, 2013

When expertise is applied in a new field

Chief information officer improved supply of drugs

Week in Review Jan 25, 2013

Week in Review, January 26

Novartis appoints a friendly German as Huawei pledges to open up

MOST POPULAR NOW ON FT.COM

COMPANIES NEWS ON TWITTER

More FT Twitter accounts